Survey of acyclovir-resistant herpes simplex virus in the Netherlands: Prevalence and characterization

Journal of Clinical Virology

Volumn 32, Issue 1, 2005, Pages 7-18

  Stránská, Růžena ^a   Schuurman, Rob ^a   Nienhuis, Elske ^a   Goedegebuure, Irma W ^a   Polman, Merjo ^a   Weel, Jan F ^b   Wertheim Van Dillen, Pauline M ^b   Berkhout, Ron J M ^c   Van Loon, Anton M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

ACV; acyclovir; CMV; CV; cytomegalovirus; DNA pol; DNA polymerase; foscarnet; ganciclovir; GCV; hematopoietic stem cell transplantation; herpes simplex virus; HFF; HSCT; HSV; human foreskin fibroblasts; PFA; sexually transmitted disease; STD; thymidine kinase; TK

Indexed keywords

ACICLOVIR; FOSCARNET; IMMUNOSUPPRESSIVE AGENT; THYMIDINE KINASE;

ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CONFIDENCE INTERVAL; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG USE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEALTH SURVEY; HEMATOLOGIC DISEASE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; SCREENING; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS SHEDDING;

ACYCLOVIR; ADULT; DRUG RESISTANCE, VIRAL; FEMALE; HERPES SIMPLEX; HUMANS; IMMUNOCOMPETENCE; MALE; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PREVALENCE; SIMPLEXVIRUS;

EID: 9644252743     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.04.002     Document Type: Article

References (54)

1. Andrei G., Snoeck R., De Clercq E., Esnouf R., Fiten P., Opdenakker G. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. J. Gen. Virol. 81:2000;639-648
2. Bacon T.H., Boon R.J., Schultz M., Hodges-Savola C. Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis. Antimicrob. Agents Chemother. 46:2002;3042-3044
3. Bacon T.H., Levin M.J., Leary J.J., Sarisky R.T., Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin. Microbiol. Rev. 16:2003;114-128
4. Balasubramaniam N.K., Veerisetty V., Gentry G.A. Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. J. Gen. Virol. 71:1990;2979-2987
5. Bergmann O.J., Ellermann-Eriksen S., Mogensen S.C., Ellegaard J. Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial. BMJ. 310:1995;1169-1172
6. Bestman-Smith J., Boivin G. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids. J. Virol. 77:2003;7820-7829
7. Bestman-Smith J., Schmit I., Papadopoulou B., Boivin G. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J. Virol. 75:2001;3105-3110
8. Black M.E., Loeb L.A. Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro. Biochemistry. 32:1993;11618-11626
9. Boivin G. Drug-resistant herpesviruses: should we look for them? Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;539-541
10. Boon R.J., Bacon T.H., Robey H.L., Coleman T.J., Connolly A., Crosson P., et al. Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey. J. Antimicrob. Chemother. 46:2000;1051
11. Brown D.G., Visse R., Sandhu G., Davies A., Rizkallah P.J., Melitz C., et al. Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir. Nat. Struct. Biol. 2:1995;876-881
12. Chen Y., Scieux C., Garrait V., Socie G., Rocha V., Molina J.M., et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin. Infect. Dis. 31:2001;927-935
13. Christophers J., Clayton J., Craske J., Ward R., Collins P., Trowbridge M., et al. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob. Agents Chemother. 42:1998;868-872
14. Coen D.M., Furman P.A., Gelep P.T., Schaffer P.A. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D- arabinofuranosyladenine. J. Virol. 41:1982;909-918
15. Coen D.M., Kosz-Vnenchak M., Jacobson J.G., Leib D.A., Bogard C.L., Schaffer P.A., et al. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. U.S.A. 86:1989;4736-4740
16. Collins P, Ellis MN. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol 1993;Suppl 1:58-66.
17. Danve C., Morfin F., Thouvenot D., Aymard M. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir. J. Virol. Methods. 105:2002;207-217
18. Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004;42:24-9.
19. Dignani M.C., Mykietiuk A., Michelet M., Intile D., Mammana L., Desmery P., et al. Valacyclovir prophylaxis for the prevention of herpes simplex virus reactivation in recipients of progenitor cells transplantation. Bone Marrow Transplant. 29:2002;263-267
20. Englund J.A., Zimmerman M.E., Swierkosz E.M., Goodman J.L., Scholl D.R., Balfour H.H. Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann. Intern. Med. 112:1990;416-422
21. Gaudreau A., Hill E., Balfour H.H. Jr., Erice A., Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178:1998;297-303
22. Gilbert C., Bestman-Smith J., Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist. Updat. 5:2002;88-114
23. Halpern M.E., Smiley J.R. Effects of deletions on expression of the herpes simplex virus thymidine kinase gene from the intact viral genome: the amino terminus of the enzyme is dispensable for catalytic activity. J. Virol. 50:1984;733-738
24. Kit S., Sheppard M., Ichimura H., Nusinoff-Lehrman S., Ellis M.N., Fyfe J.A., et al. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir. Antimicrob. Agents Chemother. 31:1987;1483-1490
25. Langston A.A., Redei I., Caliendo A.M., Somani J., Hutcherson D., Lonial S., et al. Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood. 99:2002;1085-1088
26. Larder B.A., Darby G. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology. 146:1985;262-271
27. Larder B.A., Darby G. Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir. Antimicrob. Agents Chemother. 29:1986;894-898
28. Leahy B.J., Christiansen K.J., Shellam G. Standardisation of a microplate in situ ELISA (MISE-test) for the susceptibility testing of herpes simplex virus to acyclovir. J. Virol. Methods. 48:1994;93-108
29. Liu Q.Y., Summers W.C. Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: effects on catalytic activity. Virology. 163:1988;638-642
30. Meyers J.D., Flournoy N., Thomas E.D. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J. Infect. Dis. 142:1980;338-346
31. Morfin F., Souillet G., Bilger K., Ooka T., Aymard M., Thouvenot D. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J. Infect. Dis. 182:2000;290-293
32. Nugier F., Colin J.N., Aymard M., Langlois M. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J. Med. Virol. 36:1992;1-12
33. Palu G., Gerna G., Bevilacqua F., Marcello A. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. Virus Res. 25:1992;133-144
34. Parris D.S., Harrington J.E. Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates. Antimicrob. Agents Chemother. 22:1982;71-77
35. Pelosi E., Rozenberg F., Coen D.M., Tyler K.L. A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice. Virology. 252:1998;364-372
36. Rabella N., Otegui M., Labeaga R., Rodriguez P., Margall N., Gurgui M., et al. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience. Clin. Infect. Dis. 34:2002;1055-1060
37. Reyes M., Shaik N.S., Graber J.M., Nisenbaum R., Wetherall N.T., Fukuda K., et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch. Intern. Med. 163:2003;76-80
38. Sarisky R.T., Crosson P., Cano R., Quail M.R., Nguyen T.T., Wittrock R.J., et al. Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility. J. Clin. Virol. 23:2002;191-200
39. Sarisky R.T., Nguyen T.T., Duffy K.E., Wittrock R.J., Leary J.J. Difference in incidence of spontaneous mutations between herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother. 44:2000;1524-1529
40. Sarisky R.T., Quail M.R., Clark P.E., Nguyen T.T., Halsey W.S., Wittrock R.J., et al. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J. Virol. 75:2001;1761-1769
41. Sasadeusz J.J., Tufaro F., Safrin S., Schubert K., Hubinette M.M., Cheung P.K., et al. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 71:1997;3872-3878
42. Schulz G.E., Muller C.W., Diederichs K. Induced-fit movements in adenylate kinases. J. Mol. Biol. 213:1990;627-630
43. Shepp D.H., Dandliker P.S., Flournoy N., Meyers J.D. Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients. Transplantation. 43:1987;654-658
44. Spruance S.L., Jones T.M., Blatter M.M., Vargas-Cortes M., Barber J., Hill J., et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob. Agents Chemother. 47:2003;1072-1080
45. Stranska R, Scholl DR, Jollick J, et al. ELVIRA HSV- a rapid assay for antiviral resistance testing of herpes simplex virus. Antimicrob Agents Chemother 2004a; 48:2331-33.
46. Stranska R, van Loon AM, Bredius RG, Polman M, Nienhus E, Beersma MFC, et al. Sequential switching of DNA polymerase and thymidine kinase mediated HSV-1 drug resistance in an immunocompromised child. Antivir Ther 2004b;9:97-104.
47. Stranska R, van Loon AM, Polman M, et al. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from hematopoietic stem cell transplant recipients. Antivir Ther 2004c; in press.
48. Swierkosz EM. Antiviral Susceptibilty Testing. In: Specter S, Hodinka RL, Young SA, editors. Antiviral Drug Suceptibilty Testing. Washington, DC: ASM Press; 2000:154-68.
49. Vogt J., Perozzo R., Pautsch A., Prota A., Schelling P., Pilger B., et al. Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography. Proteins. 41:2000;545-553
50. Wade J.C., McLaren C., Meyers J.D. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J. Infect. Dis. 148:1983;1077-1082
51. Whitley R.J., Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin. Infect. Dis. 20:1995;414-420
52. Wild K., Bohner T., Aubry A., Folkers G., Schulz G.E. The three-dimensional structure of thymidine kinase from herpes simplex virus type 1. FEBS Lett. 368:1995;289-292
53. Williamson E.C., Millar M.R., Steward C.G., Cornish J.M., Foot A., Oakhill A., et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br. J. Haematol. 104:1999;560-568
54. Wood M.J. Viral infections in neutropenia - current problems and chemotherapeutic control. J. Antimicrob. Chemother. 41(Suppl. D):1998;81-93